User profiles for Deependra Kumar Rai

Deependra Rai

Additional Professor, Pulmonary Medicine, AIIMS Patna
Verified email at aiimspatna.org
Cited by 429

Post covid 19 pulmonary fibrosis. Is it real threat?

DK Rai, P Sharma, R Kumar - Indian journal of tuberculosis, 2021 - Elsevier
After the COVID-19 outbreak, increasing number of patients worldwide who have survived
COVID-19 continue to battle the symptoms of the illness, long after they have been clinically …

Ivermectin as a potential treatment for mild to moderate COVID-19–a double blind randomized placebo-controlled trial

…, B Biswas, PK Majhi, DK Rai, Shyama, A Kumar… - MedRxiv, 2021 - medrxiv.org
Objective Ivermectin has been suggested as a treatment for COVID-19.This randomised
control trial was conducted to test the efficacy of Ivermectin in the treatment of mild and …

[HTML][HTML] Interim analysis of impact of adding low dose pulmonary radiotherapy to moderate COVID-19 pneumonia patients: IMpact-RT study

P Singh, A Mandal, D Singh, S Kumar, A Kumar… - Frontiers in …, 2022 - frontiersin.org
Purpose: Treatment for coronavirus disease 2019 (COVID-19) pneumonia remains largely
supportive till date and multiple clinical trials took place within the short span of time to …

[HTML][HTML] Problems faced by tuberculosis patients during COVID-19 pandemic: Urgent need to intervene

DK Rai, R Kumar, SK Pandey - The Indian Journal of Tuberculosis, 2020 - ncbi.nlm.nih.gov
1. Method Patients getting treatment for drug sensitive pulmonary or extra-pulmonary
tuberculosis who were in the intensive phase of treatment from AIIMS-Patna were included for …

[HTML][HTML] Palliative care in drug resistance tuberculosis: an overlooked component in management

DK Rai, P Sharma - Indian Journal of Palliative Care, 2023 - ncbi.nlm.nih.gov
Palliative care should be an important component in the management of drug resistant
tuberculosis (DRTB); however, it is not given much importance. Even in the current scenario, …

Post-COVID-19 respiratory management: expert panel report.

R Kumar, D Behera, SK Jindal, B Menon, N Goel… - 2020 - cabidigitallibrary.org
This report is the first expert panel report on the management of post-COVID-19 patients from
India. The report contains high risk groups, post-COVID-19 patient management at primary …

A Hospital-based cross-sectional study on clinico-demographic characteristic of extrapulmonary tuberculosis cases coming to a tertiary hospital of Bihar

DK Rai, S Pandey - Indian Journal of Community Medicine, 2018 - journals.lww.com
Though India is the second-most populous country in the world one-fourth of the global
incident tuberculosis (TB) cases occur in India annually. As per the WHO Global TB Report,[1] …

Clinical characteristics and treatment outcome in Tubercular lymphadenitis patients-A prospective observational study

DK Rai, R Kumar, S Ahmad - Indian Journal of Tuberculosis, 2020 - Elsevier
Background Tuberculous lymphadenitis is the most common form of extrapulmonary
tuberculosis. This study was primarily designed to assess clinical characteristics of Peripheral …

[PDF][PDF] PostCOVID-19 pulmonary fibrosis: report of two cases

S Karmakar, P Sharma, A Harishkumar, DK Rai - EMJ Respir, 2021 - academia.edu
COVID-19 caused by severe acute respiratory syndrome coronavirus 2 has led to a pandemic
situation worldwide. However, remarkable progress has been made in evolving policies, …

Fentanyl vs dexmedetomidine nebulization as adjuvant to lignocaine: A comparative study during awake flexible fiberoptic bronchoscopy

…, A Kumar, C Sinha, A Kumar, DK Rai, R Kumar - Trends in Anaesthesia …, 2021 - Elsevier
Background and aims Flexible fiberoptic bronchoscopy is used to diagnose diseases of the
tracheobronchial tree and to obtain samples. Methods used for awake flexible fiberoptic …